Sample | NG-MAST | MLST | Polymorphism in | Presence of | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
mtrR*†‡§ | penB*† | penA genotype*† | rpsJ§ | gyrA¶ | parC¶ | ponA* | 23S rRNA gene‡ | Penicillinase-encoding plasmid* | TetM-encoding plasmid§ | |||
S1 | 9920 | 7363 | A39T | A121G | II | WT | WT | WT | L421P | WT | No | No |
S2 | 8709 | 9363 | A39T | WT | II | V57M | WT | WT | WT | WT | No | No |
S3 | 21 | 1579 | Deletion of A** | G120K A121G | IX (D345a, A501V, P551L) | V57M | WT | WT | L421P | C2611T (4)†† | No | No |
S4 | 7138 | 11 430‡‡ | A39T | WT | II | WT | WT | WT | WT | WT | No | No |
S5 | 12 424‡‡ | 11 431‡‡ | A39T | WT | II | V57M | S91F, D95A | E91G | WT | WT | Yes | No |
S6 | 9654 | 11 428 | A39T | WT | II | V57M | WT | WT | WT | WT | No | No |
S7 | 12 425‡‡ | 8134 | A39T | A121G | II | V57M | WT | WT | WT | WT | Yes | Yes |
S8 | 4822 | 1901 | Deletion of A | G120K A121N | XXXIV (Mosaic allele) | V57M | S91F, D95G | S87R | L421P | C2611T (2) | No | No |
S9 | 10 558 | 9363 | A39T | WT | II | V57M | WT | WT | WT | WT | No | No |
S10 | 9909 | 7359 | A39T | WT | II | WT | WT | WT | WT | WT | No | No |
S11 | 4186 | 7359 | A39T | WT | II | WT | WT | WT | WT | WT | No | No |
*Associated with decreased susceptibility/resistance to penicillin.
†Associated with decreased susceptibility to cephalosporins.
‡Associated with decreased susceptibility to azithromycin.
§Associated with decreased susceptibility/resistance to tetracycline.
¶Associated with decreased susceptibility to quinolones.
**Contains an A deletion in the 13 bp inverted repeat region of the mtrR promoter.
††Parentheses indicate number of alleles with this mutation.
‡‡STs not previously identified.
STs, sequence types; WT, wild type.